Research Alliance Corp II (RACB) Financials

$10.11

$0.00 (0.00%)

As on 15-Dec-2022 09:30EDT

Market cap

$194 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

168.4

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.80	0.47	--	--	--	--
Gross Profit	-0.80	-0.47	--	--	--	--
Operating Expenses	0.80	0.47	--	--	--	--
Operating Profit (EBIT)	-0.80	-0.47	-0.01	--	--	--
Other Income	0.87	0.01	--	--	--	--
Profit before Tax	0.06	-0.46	-0.01	--	--	--
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	0.06	-0.46	-0.01	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	0.06	-0.46	-0.02	--	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	145.57	-4.14	0.02	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.23	5.23	--	--	--	--
Current Liabilities	0.07	0.18	0.33	--	--	--
Total Liabilities	150.94	150.77	0.35	--	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	150.37	149.51	0.12	--	--	--
Current Assets	0.50	1.26	0.22	--	--	--
Total Assets	150.94	1.27	0.35	--	--	--
Total Debt*	--	--	0.30	--	--	--
Net Current Assets	0.43	1.08	-0.11	--	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-0.52	-0.01	--	--	--
Cash Flow from Investing Activities	--	-149.50	-149.50	--	--	--
Cash from Financing Activities	--	150.85	0.55	--	--	--
Net Cash Inflow / Outflow	--	0.83	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	0.02	-0.11	--	--	--	--
Cash EPS ($)	--	-0.11	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.13	--	--	--	--
Free Cash Flow per Share ($)	--	-0.13	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	23.83	--	--	--	--
ROE (%)	0.04	22.10	--	--	--	--
ROA (%)	0.04	-0.60	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	7.28	-3,919.59	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-95.61	-2,316.05	--	--	--	--
Net Profit Growth (%)	120.39	-5,701.59	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	0.04	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	168.42	-85.70	--	--	--	--
Price / Book Value	1.33	-9.43	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-241.25	-83.40	--	--	--	--
Close Price ($)	9.83	9.77	--	--	--	--
High Price ($)	9.96	11.33	--	--	--	--
Low Price ($)	9.64	9.66	--	--	--	--
Market Cap ($ Cr)	193.88	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	17.51	--	--	--
Short term debt to equity ratio	--	--	17.51	--	--	--
Current Ratio	7.31	7.04	0.68	--	--	--
Quick Ratio	7.31	--	--	--	--	--
Interest Coverage	1.07	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	10.54	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.